Brandinium

Trademark search for:

GLIMMUNE THERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-05-02 — Application filed
  • 2023-05-05 — Application filed
  • 2023-05-31 — Application filed
  • 2024-01-23 — Assigned to examiner
  • 2024-01-26 — Approved for pub - principal register
  • 2024-02-14 — Notification of notice of publication e-mailed
  • 2024-02-14 — Official gazette publication confirmation e-mailed
  • 2024-03-05 — Published for opposition
  • 2024-03-05 — Official gazette publication confirmation e-mailed
  • 2024-04-30 — Noa e-mailed - sou required from applicant
  • 2024-12-02 — Application abandoned
  • 2024-12-02 — Application abandoned
  • 2024-12-02 — Final status recorded

Owner Information

Glenmark Pharmaceuticals Limited
Mumbai IN
Glenmark Pharmaceuticals Limited
Mumbai IN

Correspondent

MAXIM A. VOLTCHENKO KAPLAN BREYER SCHWARZ, LLP
197 STATE ROUTE 18, STE 3000
SOUTH WING
EAST BRUNSWICK, NJ 08816

Filing Details

Filing Date:
2023-05-02
Status Date:
2024-12-02
Category:
Pharmaceuticals
Filing Year:
2019

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.